Home › Compare › KALO vs QYLD

KALO vs QYLD: Dividend Comparison 2026

KALO yields 666666.67% · QYLD yields 11.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KALO wins by $8.275235618773884e+34M in total portfolio value
10 years
KALO
KALO
● Live price
666666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.275235618773884e+34M
Annual income
$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00
Full KALO calculator →
QYLD
Global X Nasdaq 100 Covered Call ETF
● Live price
11.92%
Share price
$17.15
Annual div
$2.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.4K
Annual income
$5,659.31
Full QYLD calculator →

Portfolio growth — KALO vs QYLD

📍 KALO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKALOQYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KALO + QYLD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
KALO pays
QYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KALO
Annual income on $10K today (after 15% tax)
$56,666,666.67/yr
After 10yr DRIP, annual income (after tax)
$70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/yr
QYLD
Annual income on $10K today (after 15% tax)
$1,013.51/yr
After 10yr DRIP, annual income (after tax)
$4,810.41/yr
At 15% tax rate, KALO beats the other by $70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KALO + QYLD for your $10,000?

KALO: 50%QYLD: 50%
100% QYLD50/50100% KALO
Portfolio after 10yr
$4.137617809386942e+34M
Annual income
$41,363,972,714,609,160,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.97%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KALO buys
0
QYLD buys
0
No recent congressional trades found for KALO or QYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKALOQYLD
Forward yield666666.67% ✓11.92%
Annual dividend / share$2.00$2.04 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$8.275235618773884e+34M$25.4K ✓
Annual income after 10y$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00 ✓$5,659.31
Total dividends collected$8.275075881065991e+34M$27.1K ✓
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: KALO vs QYLD ($10,000, DRIP)

YearKALO PortfolioKALO Income/yrQYLD PortfolioQYLD Income/yrGap
1← crossover$66,677,367$66,666,666.67$10,352$1,192.36+$66.67M → KALO
2$415,506,651,117$415,435,306,334.37$10,830$1,347.57+$415506.64M → KALO
3$2,419,908,598,386,268$2,419,464,006,269,573.00$11,460$1,539.07+$2419908598.37M → KALO
4$13,171,697,643,084,456,000$13,169,108,340,884,183,000.00$12,275$1,777.84+$13171697643084.44M → KALO
5$67,004,927,492,790,120,000,000$66,990,833,776,312,020,000,000.00$13,323$2,078.95+$67004927492790120.00M → KALO
6$318,562,277,003,514,840,000,000,000$318,490,581,731,097,560,000,000,000.00$14,667$2,463.34+$318562277003514871808.00M → KALO
7$1,415,484,168,853,553,000,000,000,000,000$1,415,143,307,217,159,200,000,000,000,000.00$16,396$2,960.57+$1.415484168853553e+24M → KALO
8$5,878,130,573,362,507,000,000,000,000,000,000$5,876,616,005,301,833,000,000,000,000,000,000.00$18,631$3,612.97+$5.878130573362507e+27M → KALO
9$22,813,793,009,840,743,000,000,000,000,000,000,000$22,807,503,410,127,248,000,000,000,000,000,000,000.00$21,548$4,482.15+$2.2813793009840744e+31M → KALO
10$82,752,356,187,738,840,000,000,000,000,000,000,000,000$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00$25,398$5,659.31+$8.275235618773884e+34M → KALO

KALO vs QYLD: Complete Analysis 2026

KALO — Stock

Kallo Inc., together with its subsidiaries, focuses on developing medical information technology software. The company's products in development include Electronic Medical Records (EMR) Integration Engine, a software, which connects various other applications in or outside a hospital/clinic with the EMR system; Communicable and Infectious Disease Information Management System, an Internet-based solution for monitoring and managing communicable and infectious disease information; and Clinical-Care Globalization, a clinical-care globalization technology. Its products also include MC-Telehealth, a mobile clinic with telehealth system technology; Kallo Integrated Delivery System (KIDS), a technology and process framework that defines and describes the component parts of the various products and services; and KIDS Global Tele-Health Ecosystems, a Tele-health Program that encompasses various technologies and administrative processes needed to deliver virtual medical care, health promotion/prevention, and other patient education to KIDS patients. The company was formerly known as Diamond Technologies Inc. The company was incorporated in 2006 and is headquartered in Toronto, Canada.

Full KALO Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →
📬

Get this KALO vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KALO vs SCHDKALO vs JEPIKALO vs OKALO vs KOKALO vs MAINKALO vs XYLDKALO vs JEPQKALO vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.